AstraZeneca vaccine: Therapy for rare cerebral vein thrombosis found

 Professor Andreas Greinacher hung in and it was worth it. The complications following vaccination with the AstraZeneca vaccine have been researched and a therapy has been developed. So nothing stands in the way of a further vaccination.

The antibody, which in rare cases is formed after vaccination, activates the blood platelets. These then act like wound healing and trigger thrombosis in the brain.

The Greifswald scientist examined blood samples from those affected and developed a therapy together with European scientists and the Paul Ehrlich Institute. Since these results have already been widely transmitted to clinics, vaccination can continue with AstraZeneca. Affected people can be treated directly.

Downloads:

• Video recording of the press conference

https://www.medizin.uni-greifswald.de/de/ueber-die-umg/aktuelles/astrazeneca-impfung/